Literature DB >> 11317012

ABT 378/r: a novel inhibitor of HIV-1 protease in haemodialysis.

H Izzedine, V Launay-Vacher, M Legrand, D Lieberherr, E Caumes, G Deray.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11317012     DOI: 10.1097/00002030-200103300-00024

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  5 in total

1.  Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Gregory M Lucas; Michael J Ross; Peter G Stock; Michael G Shlipak; Christina M Wyatt; Samir K Gupta; Mohamed G Atta; Kara K Wools-Kaloustian; Paul A Pham; Leslie A Bruggeman; Jeffrey L Lennox; Patricio E Ray; Robert C Kalayjian
Journal:  Clin Infect Dis       Date:  2014-09-17       Impact factor: 9.079

2.  The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis.

Authors:  Samir K Gupta; Susan L Rosenkranz; Yoninah S Cramer; Susan L Koletar; Lynda A Szczech; Valerianna Amorosa; Stephen D Hall
Journal:  AIDS       Date:  2008-10-01       Impact factor: 4.177

3.  Management of the kidney transplant patient with chronic hepatitis C infection.

Authors:  Ignatius Y S Tang; Natasha Walzer; Nidhi Aggarwal; Ivo Tzvetanov; Scott Cotler; Enrico Benedetti
Journal:  Int J Nephrol       Date:  2011-04-26

Review 4.  The Role of Natural Products in Drug Discovery and Development against Neglected Tropical Diseases.

Authors:  Peter Mubanga Cheuka; Godfrey Mayoka; Peggoty Mutai; Kelly Chibale
Journal:  Molecules       Date:  2016-12-31       Impact factor: 4.411

Review 5.  Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Authors:  Risto S Cvetkovic; Karen L Goa
Journal:  Drugs       Date:  2003       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.